Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8Prostatic Neoplasms 2Neoplasms 2Weight Loss 1Polyps 1Osteoporosis 1Myocardial Ischemia 1Myocardial Infarction 1Metabolic Syndrome 1Lung Neoplasms 1Heart Diseases 1Diabetes Mellitus 1Depression 1Coronary Disease 1Colonic Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1Carcinoma, Renal Cell 1Bone Diseases 1Body Weight Changes 1Angina, Unstable 1Adenoma 1

Interventions

Metformin 8Surveys and Questionnaires 3Pioglitazone 3Nutrition Assessment 3Methods 3Exercise 3Educational Status 3Tirzepatide 2Therapeutics 2Tablets 2Standard of Care 2Specimen Handling 2Resistance Training 2Interviews as Topic 2Glucose Tolerance Test 2Biopsy 2tocilizumab 1tislelizumab 1sofosbuvir-velpatasvir drug combination 1saxagliptin 1pembrolizumab 1otelixizumab 1nabiximols 1esmolol 1epalrestat 1donafenib 1dapagliflozin 1amlodipine, atorvastatin drug combination 1Verapamil 1Urine Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diabetes Mellitus × Diet, Fat-Restricted × Clear all
NCT00924937 2021-06-03

CORDIOPREV

Hospital Universitario Reina Sofia de Cordoba

Phase NA Completed
1,002 enrolled

Angina, Unstable, Diabetes Mellitus, Myocardial Infarction, Neoplasms, Metabolic Syndrome, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡